PHARMING GRP SP. ADRS Cash Flow Quality Index
PHARMING GRP SP. ADRS cash flow quality index. PHARMING GRP SP. ADRS (PHG) has a Cash Flow Quality Index of 2.01x as of December 2025. Operating cash flow of €10.71 Million exceeds net income of €5.33 Million, indicating high earnings quality where cash backs reported profits. See PHG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of PHARMING GRP SP. ADRS (2021–2025)
Cash flow quality index of PHARMING GRP SP. ADRS from 2021 to 2025. Historical Cash Flow Quality Index for PHARMING GRP SP. ADRS across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of PHARMING GRP SP. ADRS to assess how comfortably operating cash covers total debt obligations.
PHARMING GRP SP. ADRS Cash Flow Quality Index by Year (2021–2025)
PHARMING GRP SP. ADRS cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for PHARMING GRP SP. ADRS. For the full cash flow conversion analysis, see how efficiently does PHARMING GRP SP. ADRS generate cash.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 19.19x | €54.71 Million | €2.85 Million | ▲ +1068.4% |
| 2022 | 1.64x | €22.46 Million | €13.67 Million | ▼ -36.9% |
| 2021 | 2.60x | €37.84 Million | €14.54 Million | — |